Serveur d'exploration MERS - Curation (Ncbi)

Index « Keywords » - entrée « Antiviral Agents (therapeutic use) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Antiviral Agents (pharmacology) < Antiviral Agents (therapeutic use) < Antiviral Agents (toxicity)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 70.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000A90 (2013) Jean-Yves Nau[Emergency treatment for Middle Eastern coronaviruses (MERS-CoV].
000B07 (2013) Elizabeth DevittLack of small animal model hinders MERS coronavirus research
000B39 (2013) Hisham Momattin [Arabie saoudite] ; Khurram Mohammed [Arabie saoudite] ; Alimuddin Zumla [Royaume-Uni] ; Ziad A. Memish [Arabie saoudite] ; Jaffar A. Al-Tawfiq [États-Unis]Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) – possible lessons from a systematic review of SARS-CoV therapy
000B45 (2013) Darryl Falzarano ; Emmie De Wit ; Angela L. Rasmussen ; Friederike Feldmann ; Atsushi Okumura ; Dana P. Scott ; Doug Brining ; Trenton Bushmaker ; Cynthia Martellaro ; Laura Baseler ; Arndt G. Benecke [France] ; Michael G. Katze ; Vincent J. Munster ; Heinz FeldmannTreatment with interferon-α2b and ribavirin improves outcome in MERS-CoV–infected rhesus macaques
000C28 (2013) Nan Zhou ; Yun Zhang ; Jin-Chun Zhang ; Ling Feng ; Jin-Ku BaoThe receptor binding domain of MERS-CoV: The dawn of vaccine and treatment development
000C50 (2014) Jaffar A. Al-Tawfiq [Arabie saoudite, États-Unis] ; Hisham Momattin [Arabie saoudite] ; Jean Dib [Arabie saoudite] ; Ziad A. Memish [Arabie saoudite]Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study
000C68 (2014) Yaseen M. Arabi ; Ahmed A. Arifi ; Hanan H. Balkhy ; Hani Najm ; Abdulaziz S. Aldawood ; Alaa Ghabashi ; Hassan Hawa ; Adel Alothman ; Abdulaziz Khaldi ; Basel Al RaiyClinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection.
000D03 (2014) Jaffar A. Al-Tawfiq [Arabie saoudite] ; Ziad A. MemishWhat are our pharmacotherapeutic options for MERS-CoV?
000D16 (2014) David S. Hui [Royaume-Uni] ; Ziad A. Memish ; Alimuddin ZumlaSevere acute respiratory syndrome vs. the Middle East respiratory syndrome.
000D65 (2015) Mohammed Khalid [Arabie saoudite] ; Fahad Al Rabiah ; Basha Khan ; Abdullah Al Mobeireek ; Taimur S. Butt ; Eid Al MutairyRibavirin and interferon-α2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: a preliminary report of two cases.
000D66 (2014) J. Premila Devi ; W. Noraini ; R. Norhayati ; C. Chee Kheong ; A S Badrul ; S. Zainah ; K. Fadzilah ; I. Hirman ; S. Lokman Hakim ; A. Noor HishamLaboratory-confirmed case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Malaysia: preparedness and response, April 2014.
000F13 (2014) Lisa E. Gralinski [États-Unis] ; Ralph S. Baric [États-Unis]Molecular pathology of emerging coronavirus infections
000F21 (2014) Christopher M. Coleman [États-Unis] ; Matthew B. Frieman [États-Unis]Treating MERS-CoV during an outbreak
000F22 (2014) Ali S. Omrani [Arabie saoudite] ; Mustafa M. Saad [Arabie saoudite] ; Kamran Baig [Arabie saoudite] ; Abdelkarim Bahloul [Arabie saoudite] ; Mohammed Abdul-Matin [Arabie saoudite] ; Amal Y. Alaidaroos [Arabie saoudite] ; Ghaleb A. Almakhlafi [Arabie saoudite] ; Mohammed M. Albarrak [Arabie saoudite] ; Ziad A. Memish [Arabie saoudite] ; Ali M. Albarrak [Arabie saoudite]Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study
000F25 (2014) Nikolaos Spanakis [Grèce] ; Sotirios Tsiodras [Grèce] ; Bart L. Haagmans [Pays-Bas] ; V. Stalin Raj [Pays-Bas] ; Kostantinos Pontikis [Grèce] ; Antonia Koutsoukou [Grèce] ; Nikolaos G. Koulouris [Grèce] ; Albert D. M. E. Osterhaus [Pays-Bas] ; Marion P. G. Koopmans [Pays-Bas] ; Athanassios Tsakris [Grèce]Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen
000F29 (2015) Judith M A. Van Den Brand [Pays-Bas] ; Saskia L. Smits ; Bart L. HaagmansPathogenesis of Middle East respiratory syndrome coronavirus.
000F61 (2014) Aeron C. Hurt [Australie] ; David S. Hui [Hong Kong] ; Alan Hay [Royaume-Uni] ; Frederick G. Hayden [États-Unis]Overview of the 3rd isirv-Antiviral Group Conference – advances in clinical management
000F76 (2014) Shuai Xia [République populaire de Chine] ; Qi Liu [République populaire de Chine] ; Qian Wang [République populaire de Chine] ; Zhiwu Sun [République populaire de Chine] ; Shan Su [République populaire de Chine] ; Lanying Du [États-Unis] ; Tianlei Ying [République populaire de Chine] ; Lu Lu [République populaire de Chine] ; Shibo Jiang [République populaire de Chine, États-Unis]Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein
001006 (2014) Sarah Shalhoub [Arabie saoudite] ; Abdulwahab Alzahrani [Arabie saoudite] ; Raed Simhairi [Arabie saoudite] ; Adnan Mushtaq [Arabie saoudite]Successful recovery of MERS CoV pneumonia in a patient with acquired immunodeficiency syndrome: A case report
001076 (2015) Jasper F W. Chan [République populaire de Chine] ; Susanna K P. Lau [République populaire de Chine] ; Kelvin K W. To [République populaire de Chine] ; Vincent C C. Cheng [République populaire de Chine] ; Patrick C Y. Woo [République populaire de Chine] ; Kwok-Yung Yuen [Hong Kong]Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease.
001083 (2014) Mohammad Khalid ; Basha Khan ; Fahad Al Rabiah ; Ruwaida Alismaili ; Sarfraz Saleemi ; Agha Muhammad Rehan-Khaliq ; Ihab Weheba ; Hail Al Abdely ; Magid Halim ; Quaid Johar Nadri ; Abdullah Mohsin Al Dalaan ; Mohamed Zeitouni ; Taimur Butt ; Eid Al MutairyMiddle Eastern Respiratory Syndrome Corona Virus (MERS CoV): case reports from a tertiary care hospital in Saudi Arabia

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Antiviral Agents (therapeutic use)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Antiviral Agents (therapeutic use)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antiviral Agents (therapeutic use)
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021